OBJECTIVE: Castleman's disease (CD) is a rare disorder of unknown aetiology characterized by lymph node enlargement. This study evaluated the clinical features, diagnosis and outcomes of surgical treatment in patients with CD. METHODS: The medical records of 10 patients with histologically confirmed CD who underwent surgery between 2003 and 2008 were retrospectively reviewed. Study endpoints were survival and recurrence. RESULTS: The age of disease onset ranged from 11 to 63 years (median 38 years). Of the 10 patients included in the study, eight were diagnosed with localized (unicentric) CD and two with multicentric CD. All eight patients with localized (unicentric) CD were asymptomatic. Histological evidence indicated the hyaline vascular form of CD in eight patients and the plasmacytic form in the remaining two patients. The primary treatment was complete surgical resection in nine cases, and these patients were alive with no evidence of recurrence or exacerbation at the time of writing (June 2011). CONCLUSIONS: Localized (unicentric) CD is usually of the hyaline vascular form and complete surgical excision of the tumour allows full recovery in most cases.
KellerARHochholzerLCastlemanB: Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer1972; 29: 670–683.
5.
HerradaJCabanillasFRiceL: The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med1998; 128: 657–662.
6.
LarrocheCCacoubPSoulierJ: Castleman's disease and lymphoma: report of eight cases in HIV-negative patients and literature review. Am J Hematol2002; 69: 119–126.
DebatinJFSpritzerCEDunnickNR: Castleman disease of the adrenal gland: MR imaging features. AJR Am J Roentgenol1991; 157: 781–783.
9.
ShahidiHMyersJLKvalePA: Castleman's disease. Mayo Clin Proc1995; 70: 969–977.
10.
FlejsierowiczMAhmedMSKotovP: Successful treatment of aggressive HIV-associated multicentric Castleman's disease: A case report. WMJ2008; 107: 191–194.
11.
ChenCHLiuHCTungKY: Surgical outcome of superficial and deep Castleman disease. ANZ J Surg2007; 77: 339–343.
12.
CathomasG: Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus. Herpes2003; 10: 72–77.
13.
YamasakiSIinoTNakamuraM: Detection of human herpesvirus-8 in peripheral blood mononuclear cells from adult Japanese patients with multicentric Castleman's disease. Br J Haematol2003; 120: 471–477.
14.
KimJEKimCJParkIA: Clinicopathologic study of Castleman's disease in Korea. J Korean Med Sci2000; 15: 393–398.
15.
SudaTKatanoHDelsolG: HHV-8 infection status of AIDS-unrelated and AIDS-associated multicentric Castleman's disease. Pathol Int2001; 51: 671–679.
16.
YoshizakiKMatsudaTNishimotoN: Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood1989; 74: 1360–1367.
17.
BrandtSJBodineDMDunbarCE: Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest1990; 86: 592–599.
18.
ParraviciniCCorbellinoMPaulliM: Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am J Pathol1997; 151: 1517–1522.
FrizzeraGPetersonBABayrdED: A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol1985; 3: 1202–1216.
26.
SoulierJGrolletLOksenhendlerE: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood1995; 86: 1276–1280.
27.
DispenzieriAKyleRALacyMQ: POEMS syndrome: definitions and long-term outcome. Blood2003; 101: 2496–2506.
28.
SannaGBaroneDMidiriM: Ultrasonographic features, with color Doppler, with computerized tomography and angiography in a case of abdominal Castleman's disease. Radiol Med1997; 93: 804–805 [in Italian].
FerrozziFTogniniGSpaggiariE: Focal Castleman disease of the lung: MRI findings. Clin Imaging2001; 25: 400–402.
31.
OidaYShimizuKMukaiM: FDG-PET and diffusion-weighted MR imaging appearance in retroperitoneal Castleman's disease: A case report. Clin Imaging2008; 32: 144–146.
32.
TwistCJLinkMP: Assessment of lymphadenopathy in children. Pediatr Clin North Am2002; 49: 1009–1025.
33.
BucherPChassotGZuffereyG: Surgical management of abdominal and retroperitoneal Castleman's disease. World J Surg Oncol2005; 3: 33.
34.
ChronowskiGMHaCSWilderRB: Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer2001; 92: 670–676.
35.
MenkeDMCamorianoJKBanksPM: Angiofollicular lymph node hyperplasia: A comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis. Mod Pathol1992; 5: 525–530.
36.
BowneWBLewisJJFilippaDA: The management of unicentric and multicentric Castleman's disease: A report of 16 cases and a review of the literature. Cancer1999; 85: 706–717.
37.
KoSFNgSHHsiehMJ: Castleman disease of the pleura: experience with eight surgically proven cases. Ann Thorac Surg2003; 76: 219–224.
38.
van RheeFStoneKSzmaniaS: Castleman disease in the 21st Century: an update on diagnosis, assessment, and therapy. Clin Adv Hematol Oncol2010; 8: 486–498.
39.
WalkerFRHodylNAKrivanekKM: Early life host—bacteria relations and development: long-term individual differences in neuroimmune function following neonatal endotoxin challenge. Physiol Behav2006; 87: 126–134.
40.
SolimanTHetzHBurghuberC: Short-term versus long-term induction therapy with antithymocyte globulin in orthotopic liver transplantation. Transpl Int2007; 20: 447–452.
41.
WeisenburgerDDNathwaniBNWinbergCD: Multicentric angiofollicular lymph node hyperplasia: A clinicopathologic study of 16 cases. Hum Pathol1985; 16: 162–172.
42.
FeigertJMSweetDLColemanM: Multicentric angiofollicular lymph node hyperplasia with peripheral neuropathy, pseudotumor cerebri, IgA dysproteinemia, and thrombocytosis in women. A distinct syndrome. Ann Intern Med1990; 113: 362–367.
43.
PavlidisNASkopouliFNBaiMC: A successfully treated case of multicentric angiofollicular hyperplasia with oral chemotherapy (Castleman's disease). Med Pediatr Oncol1990; 18: 333–335.
CasqueroABarrosoAGuerreroML Fernández: Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease. Ann Hematol2006; 85: 185–187.
46.
IdeMKawachiYIzumiY: Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab. Eur J Haematol2006; 76: 119–123.
47.
MarcelinAGAaronLMateusC: Rituximab therapy for HIV-associated Castleman disease. Blood2003; 102: 2786–2788.
48.
OcioEMSanchez-GuijoFMDiez-CampeloM: Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena. Am J Hematol2005; 78: 302–305.
49.
StebbingJPantanowitzLDayyaniF: HIV-associated multicentric Castleman's disease. Am J Hematol2008; 83: 498–503.
50.
MaSHLiuQJZhangYC: Diagnosis and surgical treatment of Castleman's disease. Zhonghua Yi Xue Za Zhi2011; 91: 1118–1121 [in Chinese, English abstract].
